Reduction of chronic graft injury with a new HTK-based preservation solution in a murine heart transplantation model.

[1]  T. Billiar,et al.  Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors? , 2011, The Annals of thoracic surgery.

[2]  A. Kribben,et al.  Prolonged cold storage using a new histidine-tryptophan-ketoglutarate-based preservation solution in isogeneic cardiac mouse grafts. , 2011, European heart journal.

[3]  T. Minor,et al.  Use of a new modified HTK solution for machine preservation of marginal liver grafts. , 2010, The Journal of surgical research.

[4]  J. Luketich,et al.  Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. , 2010, Surgery.

[5]  M. Karck,et al.  Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection. , 2010, Interactive cardiovascular and thoracic surgery.

[6]  F. Sack,et al.  Myocardial protection with the use of L-arginine and N-alpha-acetyl-histidine. , 2009, Transplantation proceedings.

[7]  H. de Groot,et al.  Evaluation of a Modified HTK Solution Containing the New Iron Chelator LK 614 in an Isolated Rat Liver Perfusion Model , 2009, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[8]  Chris A Rogers,et al.  The Importance of Cold and Warm Cardiac Ischemia for Survival After Heart Transplantation , 2008, Transplantation.

[9]  A. Kribben,et al.  Novel technique for blood circuit reconstruction in mouse heart transplantation model , 2008, Microsurgery.

[10]  H. de Groot,et al.  Inherent toxicity of organ preservation solutions to cultured hepatocytes. , 2008, Cryobiology.

[11]  J. Mehta,et al.  LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. , 2007, Cardiovascular research.

[12]  S. Visovatti,et al.  Riboflavin-Mediated Reduction of Oxidant Injury, Rejection, and Vasculopathy after Cardiac Allotransplantation , 2007, Transplantation.

[13]  A. Haverich,et al.  Glycine application and right heart function in a porcine heart transplantation model , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  M. Büchler,et al.  HEGPOL: Randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312] , 2005, BMC surgery.

[15]  M. Büchler,et al.  New aspects on reperfusion injury to liver--impact of organ harvest. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  P. Schemmer,et al.  L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent , 2003, Current opinion in clinical nutrition and metabolic care.

[18]  C. Herfarth,et al.  Extended experience with glycine for prevention of reperfusion injury after human liver transplantation. , 2002, Transplantation proceedings.

[19]  D. Pinsky,et al.  Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1) , 2002, Circulation research.

[20]  M. Manyalich,et al.  Reduced reperfusion injury by glycine in a porcine liver transplantation model with non-heart-beating donors. , 2002, Transplantation proceedings.

[21]  J. Lemasters,et al.  Carolina rinse solution minimizes kidney injury and improves graft function and survival after prolonged cold ischemia1 , 2002, Transplantation.

[22]  M. Amrani,et al.  The effect of chronic L-arginine administration on vascular recovery following cold cardioplegic arrest in rats. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  John C. Hall,et al.  Influence of glycine on intestinal ischemia-reperfusion injury. , 2002, JPEN. Journal of parenteral and enteral nutrition.

[24]  I. Rusyn,et al.  Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo. , 2002, American journal of physiology. Renal physiology.

[25]  I. Rusyn,et al.  Endothelial Cells Contain a Glycine-Gated Chloride Channel , 2001, Nutrition and cancer.

[26]  H. de Groot,et al.  A ROLE FOR SODIUM IN HYPOXIC BUT NOT IN HYPOTHERMIC INJURY TO HEPATOCYTES AND LLC-PK 1 CELLS1 , 2000, Transplantation.

[27]  Y. Takei,et al.  Glycine Prevents Apoptosis of Rat Sinusoidal Endothelial Cells Caused by Deprivation of Vascular Endothelial Growth Factor , 2000, Hepatology.

[28]  V. Petrov,et al.  Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.

[29]  P. Hasleton,et al.  Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation , 2000 .

[30]  G. Bellomo,et al.  Alterations of Na(+) homeostasis in hepatocyte reoxygenation injury. , 2000, Biochimica et biophysica acta.

[31]  J. Weinberg,et al.  Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Menasché,et al.  Coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: patterns and contributing factors. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  H. Oku,et al.  Prolonged hypothermic cardiac storage with histidine-tryptophan-ketoglutarate solution: comparison with glucose-insulin-potassium and University of Wisconsin solutions. , 1997, Transplantation.

[34]  P. Giacomoni,et al.  The role of DNA damage in the cytotoxic response to hydrogen peroxide/histidine. , 1997, General pharmacology.

[35]  G. Bellomo,et al.  Glycine protects against hepatocyte killing by KCN or hypoxia by preventing intracellular Na+ overload in the rat , 1997, Hepatology.

[36]  M. Hölscher,et al.  Current status of the HTK solution of Bretschneider in organ preservation. , 1991, Transplantation proceedings.

[37]  J H Southard,et al.  Principles of solid-organ preservation by cold storage. , 1988, Transplantation.

[38]  J. Kresh,et al.  The relative buffering power of cardioplegic solutions. , 1987, Journal of Thoracic and Cardiovascular Surgery.

[39]  R. Corry,et al.  Suppressor cell induction in donor-specific transfused mouse heart recipients. , 1984, Surgery.

[40]  U. Rauen,et al.  Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators , 2006, Cellular and Molecular Life Sciences.

[41]  P. Neuhaus,et al.  Untersuchungen zum osmotikazusatz in leberkonservierungslösungen in einem modell der in-vitro-konservierung an hepatozyten , 2004, Langenbecks Archiv für Chirurgie.

[42]  H. de Groot,et al.  Protection by glycine against hypoxic injury of rat hepatocytes: inhibition of ion fluxes through nonspecific leaks. , 2000, Journal of hepatology.

[43]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[44]  J. Weinberg,et al.  Mechanisms of cell injury in ATP-depleted proximal tubules. Role of glycine, calcium, and polyphosphoinositides. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.